Skip to main content
Top
Published in: Allergy, Asthma & Clinical Immunology 1/2018

Open Access 01-12-2018 | Case report

First reported case in Canada of anaphylaxis to lupine in a child with peanut allergy

Authors: Lianne Soller, Sebastien La Vieille, Edmond S. Chan

Published in: Allergy, Asthma & Clinical Immunology | Issue 1/2018

Login to get access

Abstract

Background

Lupine is a member of the legume family and is often used in many food products in Europe (e.g. pasta, pizza, sauces, etc.) as a wheat or soy substitute. Lupine cross-reacts with peanut, and cases of allergic reactions to lupine in peanut-allergic patients have been reported in Europe mainly. In contrast, lupine as an ingredient in food products is relatively new to the Canadian market.

Case presentation

We describe a 10-year old boy with diagnosed peanut and tree-nut allergy, who developed anaphylaxis to lupine flour in May 2017. A few minutes after eating a pre-made pancake mix that didn’t contain any of his known allergens (peanuts, tree nuts), he developed oral pruritis followed by throat tightness, severe stomach ache, lightheadedness, cough, hoarse throat, nasal congestion, sneezing, and fatigue. He refused epinephrine, but was given cetirizine. The symptoms resolved after 3 h, but he was still unwell the following day. In a conversation between the mother and the allergist, it was determined that lupine was likely the cause of the reaction. To confirm, he was brought into clinic for skin testing to lupine. Results were consistent with lupine allergy (pancake mix: 10 × 7 mm, lupine bean: 12 × 6 mm). The family has since reported this to the Canadian Food Inspection Agency, resulting in a product recall and a consumer advisory bulletin published by Health Canada.

Conclusions

This is the first reported case of allergic reaction to lupine in Canada, and highlights the need for education of Canadian families with peanut allergy as well as allergists, regarding the possibility of cross-reactivity between peanut and lupine and its new presence in the Canadian food supply. In addition, a precautionary label for those with peanut allergy who purchase products containing lupine should be considered. This case illustrates also the need for a clear mechanism for consumers and allergists to report emerging food allergens to regulatory bodies such as Health Canada.
Appendix
Available only for authorised users
Literature
1.
go back to reference Peeters KABM, Nordlee JA, Penninks AH, Chen L, Goodman RE, Bruijnzeel-Koomen CAFM, et al. Lupine allergy: not simply cross-reactivity with peanut or soy. J Allergy Clin Immunol. 2007;120:647–53.CrossRef Peeters KABM, Nordlee JA, Penninks AH, Chen L, Goodman RE, Bruijnzeel-Koomen CAFM, et al. Lupine allergy: not simply cross-reactivity with peanut or soy. J Allergy Clin Immunol. 2007;120:647–53.CrossRef
2.
go back to reference Duranti M, Consonni A, Magni C, Sessa F, Scarafoni A. The major proteins of lupin seed: characterisation and molecular properties for use as functional and nutraceutical ingredients. Trends Food Sci Technol. 2008;19:624–33.CrossRef Duranti M, Consonni A, Magni C, Sessa F, Scarafoni A. The major proteins of lupin seed: characterisation and molecular properties for use as functional and nutraceutical ingredients. Trends Food Sci Technol. 2008;19:624–33.CrossRef
3.
go back to reference Mennini M, Dahdah L, Mazzina O, Fiocchi A. Lupin and other potentially cross-reactive allergens in peanut allergy. Curr Allergy Asthma Rep. 2016;16:84.CrossRef Mennini M, Dahdah L, Mazzina O, Fiocchi A. Lupin and other potentially cross-reactive allergens in peanut allergy. Curr Allergy Asthma Rep. 2016;16:84.CrossRef
4.
go back to reference Gayraud J, Mairesse M, Fontaine JF, Thillay A, Leduc V, Rancé F, et al. The prevalence of sensitization to lupin flour in France and Belgium: a prospective study in 5,366 patients, by the Allergy Vigilance Network. Eur Ann Allergy Clin Immunol. 2009;41:17–22.PubMed Gayraud J, Mairesse M, Fontaine JF, Thillay A, Leduc V, Rancé F, et al. The prevalence of sensitization to lupin flour in France and Belgium: a prospective study in 5,366 patients, by the Allergy Vigilance Network. Eur Ann Allergy Clin Immunol. 2009;41:17–22.PubMed
5.
go back to reference Moneret-Vautrin DA, Guérin L, Kanny G, Flabbee J, Frémont S, Morisset M. Cross-allergenicity of peanut and lupine: the risk of lupine allergy in patients allergic to peanuts. J Allergy Clin Immunol. 1999;104(4):883–8.CrossRef Moneret-Vautrin DA, Guérin L, Kanny G, Flabbee J, Frémont S, Morisset M. Cross-allergenicity of peanut and lupine: the risk of lupine allergy in patients allergic to peanuts. J Allergy Clin Immunol. 1999;104(4):883–8.CrossRef
6.
go back to reference Shaw J, Roberts G, Grimshaw K, White S, Hourihane J. Lupin allergy in peanut-allergic children and teenagers. Allergy Eur J Allergy Clin Immunol. 2008;63:370–3.CrossRef Shaw J, Roberts G, Grimshaw K, White S, Hourihane J. Lupin allergy in peanut-allergic children and teenagers. Allergy Eur J Allergy Clin Immunol. 2008;63:370–3.CrossRef
7.
go back to reference Hefle, Lemanske, Bush. Adverse reaction to lupine-fortified pasta. J Allergy Clin Immunol. 1994;94:167– 72.CrossRef Hefle, Lemanske, Bush. Adverse reaction to lupine-fortified pasta. J Allergy Clin Immunol. 1994;94:167– 72.CrossRef
8.
go back to reference Koeberl M, Sharp MF, Tian R, Buddhadasa S, Clarke D. ROBERTS J. Lupine allergen detecting capability and cross-reactivity of related legumes by ELISA. Food Chem. 2018;256:105–12.CrossRef Koeberl M, Sharp MF, Tian R, Buddhadasa S, Clarke D. ROBERTS J. Lupine allergen detecting capability and cross-reactivity of related legumes by ELISA. Food Chem. 2018;256:105–12.CrossRef
9.
go back to reference Health Canada. The Canadian criteria for the establishment of new priority food allergens. Ottawa: Health Canada; 2010. Health Canada. The Canadian criteria for the establishment of new priority food allergens. Ottawa: Health Canada; 2010.
Metadata
Title
First reported case in Canada of anaphylaxis to lupine in a child with peanut allergy
Authors
Lianne Soller
Sebastien La Vieille
Edmond S. Chan
Publication date
01-12-2018
Publisher
BioMed Central
Published in
Allergy, Asthma & Clinical Immunology / Issue 1/2018
Electronic ISSN: 1710-1492
DOI
https://doi.org/10.1186/s13223-018-0303-4

Other articles of this Issue 1/2018

Allergy, Asthma & Clinical Immunology 1/2018 Go to the issue